Detalles de la búsqueda
1.
Human Secretory IgM Emerges from Plasma Cells Clonally Related to Gut Memory B Cells and Targets Highly Diverse Commensals.
Immunity
; 47(1): 118-134.e8, 2017 07 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-28709802
2.
Mammographic features of benign breast lesions and risk of subsequent breast cancer in women attending breast cancer screening.
Eur Radiol
; 32(1): 621-629, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34156554
3.
Cutaneous Involvement of Angioimmunoblastic T-Cell Lymphoma Masquerading as B-Cell Reactive Lymphoid Hyperplasia.
Am J Dermatopathol
; 44(4): e41-e45, 2022 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34966050
4.
Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma With Secondary Cutaneous Involvement: A Diagnostic Challenge.
Am J Dermatopathol
; 43(4): 300-304, 2021 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33264131
5.
Complementary value of electron microscopy and immunohistochemistry in the diagnosis of non-small cell lung cancer: A potential role for electron microscopy in the era of targeted therapy.
Ultrastruct Pathol
; 43(6): 237-247, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31810413
6.
Nasal administration of the neuroprotective candidate NeuroEPO to healthy volunteers: a randomized, parallel, open-label safety study.
BMC Neurol
; 17(1): 129, 2017 Jul 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28676085
7.
Cell-Free DNA as a Biomarker at Diagnosis and Follow-Up in 256 B and T-Cell Lymphomas.
Cancers (Basel)
; 16(2)2024 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38254810
8.
Automated quantification of stromal tumour infiltrating lymphocytes is associated with prognosis in breast cancer.
Virchows Arch
; 483(5): 655-663, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37500796
9.
P53 expression correlates with low axillary tumor burden in breast cancer.
Breast Dis
; 42(1): 429-435, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38143332
10.
Round-robin testing for LMO2 and MYC as immunohistochemical markers to screen MYC rearrangements in aggressive large B-cell lymphoma.
Virchows Arch
; 2023 Jun 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37368083
11.
Characterization and spatial distribution of the immune cell infiltrate in triple-negative breast cancer: a novel classification based on plasma cells and CD8+ T cells.
Hum Pathol
; 139: 91-105, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37517596
12.
Long-Term Risk of Breast Cancer after Diagnosis of Benign Breast Disease by Screening Mammography.
Int J Environ Res Public Health
; 19(5)2022 02 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35270331
13.
Developing and validating an individualized breast cancer risk prediction model for women attending breast cancer screening.
PLoS One
; 16(3): e0248930, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33755692
14.
Lack of expression of LMO2 clone SP51 identifies MYC rearrangements in aggressive large B-cell lymphomas.
Virchows Arch
; 479(6): 1073-1078, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33811533
15.
Evaluation of routine CT scans in the follow-up of diffuse large B-cell lymphomas.
Hematology
; 26(1): 709-715, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34547987
16.
Risk of breast cancer two years after a benign biopsy depends on the mammographic feature prompting recall.
Maturitas
; 144: 53-59, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33358209
17.
Development, Characterization, Optimization, and In Vivo Evaluation of Methacrylic Acid-Ethyl Acrylate Copolymer Nanoparticles Loaded with Glibenclamide in Diabetic Rats for Oral Administration.
Pharmaceutics
; 13(12)2021 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34959305
18.
Clinical Interest of LMO2 Testing for the Diagnosis of Aggressive Large B-Cell Lymphomas.
Cancers (Basel)
; 12(4)2020 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32260556
19.
Coordinated signals from PARP-1 and PARP-2 are required to establish a proper T cell immune response to breast tumors in mice.
Oncogene
; 39(13): 2835-2843, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32001817
20.
NK Cell Infiltrates and HLA Class I Expression in Primary HER2+ Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival.
Clin Cancer Res
; 25(5): 1535-1545, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30523021